Ion Beam ApplicationsIOBCF +2.18%82 PS Ratio is 0.79 as of Jun. 25, 2026, which is 44% below its 10-year median of 1.41. GuruFocus rates IOBCF with a GF Score™ of 82/100 and a GF Value™ of $18.71 (Fairly Valued). The stock has 10 warning signs investors should review. Among 804 Medical Devices & Instruments companies, Ion Beam Applications ranks better than 85.2% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Ion Beam Applications's share price is $18.904.
Ion Beam Applications's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $23.80. Hence, Ion Beam Applications's PS Ratio for today is 0.79.
Warning Sign:
Ion Beam Applications SA stock PS Ratio (=0.8) is close to 1-year high of 0.83.
The historical rank and industry rank for Ion Beam Applications's PS Ratio or its related term are showing as below:
IOBCF'
s PS Ratio Range Over the Past 10 Years
Min: 0.57 Med: 1.41 Max: 5.06
Current: 0.78
During the past 13 years, Ion Beam Applications's highest PS Ratio was 5.06. The lowest was 0.57. And the median was 1.41.
IOBCF's PS Ratio is ranked better than 85.2% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 2.865
vs IOBCF: 0.78
During the past 12 months, the average Revenue per Share Growth Rate of Ion Beam Applications was 21.20% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 19.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 15.60% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 7.90% per year.
During the past 13 years, Ion Beam Applications's highest 3-Year average Revenue per Share Growth Rate was 36.60% per year. The lowest was -17.70% per year. And the median was 2.40% per year.
Back to Basics: PS Ratio
Ion Beam Applications (OTCPK:IOBCF) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Ion Beam Applications's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ion Beam Applications PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ion Beam Applications's PS Ratio distribution charts can be found below:
* The bar in red indicates where Ion Beam Applications's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Ion Beam Applications's Share Price of today is $18.904.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ion Beam Applications's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $23.80.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Ion Beam Applications (IOBCF) has a PS Ratio of 0.79 as of Jun. 25, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Ion Beam Applications and its competitors. This is 44% below median its historical median of 1.41. Over the past decade, Ion Beam Applications' PS Ratio has ranged from 0.57 to 5.06. According to the industry distribution chart, Ion Beam Applications ranks #119 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 14.8%.
Is Ion Beam Applications' PS Ratio too high?
Ion Beam Applications' current PS Ratio of 0.79 is 44% below median its 10-year median of 1.41. Over the past 10 years, this metric has ranged from a low of 0.57 to a high of 5.06. The Medical Devices & Instruments industry median PS Ratio is 2.87. Ion Beam Applications' value of 0.79 is 72.4% below this industry median. Based on the distribution chart, Ion Beam Applications ranks #119 out of 804 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Ion Beam Applications has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ion Beam Applications' PS Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Ion Beam Applications ranks #119 out of 804 companies for PS Ratio. This places Ion Beam Applications in the top 15% of its industry — outperforming the majority of peers. The industry median PS Ratio is 2.87. Ion Beam Applications' value of 0.79 is 72.4% below this benchmark. Historically, Ion Beam Applications' own PS Ratio has ranged from 0.57 to 5.06 over the past decade. While the company's 10-year median is 1.41 vs. the industry median of 2.87, Ion Beam Applications has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.87, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ion Beam Applications's current PS Ratio of 0.79 is 72.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Ion Beam Applications and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ion Beam Applications's current PS Ratio is 0.79, which is 44% below median its own 10-year median of 1.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ion Beam Applications stock overvalued right now?
Based on GuruFocus' analysis, Ion Beam Applications (IOBCF) is currently considered Fairly Valued. The stock's GF Value™ is $18.71, compared to a current price of $18.90 — trading 1% above its estimated fair value. The current PS Ratio is 0.79, which is 44% below median its 10-year median of 1.41 and 72.4% below the Medical Devices & Instruments industry median of 2.87. Ion Beam Applications' overall GF Score™ is 82/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Ion Beam Applications (IOBCF), the current PS Ratio is 0.79 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ion Beam Applications (IOBCF) Overvalued in 2026?
Based on GuruFocus' analysis, Ion Beam Applications stock appears to be overvalued.
The current stock price of $18.90 is trading 1% above its estimated GF Value™ of $18.71.
GuruFocus considers Ion Beam Applications to be Fairly Valued.
Key valuation signals for IOBCF:
PS Ratio: 0.79 (44% below median its 10-year median of 1.41)
GF Value™: $18.71 vs. price of $18.90 (1% above fair value)
Industry Position: 72.4% below the Medical Devices & Instruments median (#119 of 804)
No single metric tells the full story. See the IOBCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ion Beam Applications SA develops and manufactures medical devices and software solutions. The firm operates in three segments: IBA Clinical, including Proton Therapy and Dosimetry; IBA Technologies; and IBA Corporate. Proton therapy and other accelerators contribute to the majority of sales. It offers solutions for precision cancer treatment through the use of proton beams, as well as cyclotrons used for the production of radioisotopes and industrial accelerators for sterilization and ionization. The dosimetry business sells measurement and quality assurance instruments for radiotherapy and medical imaging. The firm operates in three geographical areas: Belgium, the United States, China, Germany, and India.
82GF Score
Get the complete analysis for IOBCF
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IOBCF has been successfully added to your 
